Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

E-ISSN： 1873-5576|8|5|414-420

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.5, 2008-08, pp. : 414-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 570-594

Bentham Science Publishers

Access to resources Recommend Favorite

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 609-620

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 273-286

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy

Current Drug Delivery, Vol. 1, Iss. 3, 2004-07 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite